What is Exer?
Exer's Clinical AI platform provides objective, real-time motion assessments without the need for wearables or sensors. By leveraging AI-powered movement data, Exer offers a clinical decision support platform, giving providers accessible, scalable, and actionable information to guide patient care.
The platform is designed to enhance clinical decision-making, personalize treatment, and enable early intervention. It is used by healthcare providers to improve patient outcomes and accessibility in various specialties, including orthopedics, neurology, pain/spine, PM&R, geriatrics, and more.
Features
- Exer Scan: Assess and monitor patients for MSK-related issues without sensors, hardware, or human error.
- Exer Health: Engage patients at-home with AI-based monitoring and real-time guidance to ensure good form and protocol adherence.
- Exer IQ: Capture outcomes, analyze population health, and predict risks with standardized or custom-built validated patient response surveys.
- Exer Hands: Support for the management of dozens of acute and chronic hand and wrist disorders like rheumatoid arthritis and carpal tunnel syndrome.
- AI-Based At-Home Patient App: Allows for remote monitoring and engagement.
- In-Clinic Scan App: Facilitates quick and objective data collection.
- Real-Time Data Portal Backend: Provides instant analysis and reporting.
- Automated Billing Reports: Streamlines billing processes.
- Standardized Outcome Measures: Ensures consistent evaluation.
- Customizable Templates: Adapts to specific clinical needs.
- Daily Engagement Tools: Enhances patient adherence
Use Cases
- Orthopedic operative and conservative care
- Senior care fall prevention
- Neurological disorder evaluation and monitoring
- Primary care MSK issue identification
- Rehabilitation treatment planning and monitoring
- Health plan support for value-based care
Related Queries
Helpful for people in the following professions
Featured Tools
Join Our Newsletter
Stay updated with the latest AI tools, news, and offers by subscribing to our weekly newsletter.
